Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...

Economic Indicators - US MBA mortgage applications fell by -12.7% in the week ended September 26, with the purchase mortgage sub-index down -1.0% and the refinancing sub-index down -20.6% [1] - The September ISM manufacturing index rose +0.4 to a 7-month high of 49.1, exceeding expectations of 49.0 [6] - The September ADP employment change unexpectedly fell by -32,000, marking the largest decline in 2.5 years, while August was revised lower to -3,000 from +54,000 [5] Market Reactions - Stocks initially moved lower due to the US government shutdown, but later recovered, with the S&P 500 and Nasdaq 100 reaching new all-time highs [2][4] - The dollar index fell to a one-week low, while gold prices climbed to a record high amid risk-off sentiment [2] - Rising corporate earnings expectations are a bullish backdrop for stocks, with over 22% of S&P 500 companies providing guidance for Q3 earnings that are expected to beat analysts' expectations [8] Sector Performance - Pharmaceutical stocks rallied, with AstraZeneca closing up more than +9% and Eli Lilly up more than +8%, driven by hopes from Pfizer's deal with the US government [15] - Chipmakers and AI-infrastructure stocks also saw gains, with Super Micro Computer closing up more than +9% and Micron Technology up more than +8% [16] - Grocery retailers declined after Amazon announced a new private-label food brand, leading to Dollar Tree and Dollar General closing down more than -4% and -3% respectively [22] Upcoming Economic Data - Weekly initial unemployment claims are expected to increase by +7,000 to 225,000, and August factory orders are expected to rise by +1.4% month-over-month [9] - September nonfarm payrolls are anticipated to increase by +51,000, with the unemployment rate expected to remain unchanged at 4.3% [9]

Core Insights - Women We Admire has announced The Top 50 Women Leaders of New York for 2025, highlighting the city's role as a cultural and commercial powerhouse with over 20 million residents [1] Group 1: Honorees - Shilpa Bangera, President and Global Head of Payments at Adyen, is recognized for her leadership in fintech, focusing on growth, innovation, and teamwork [2] - Emma Andrews, Vice President of Global Patient Advocacy at Pfizer, is honored for her efforts in embedding the patient perspective in company initiatives, aiming to improve patient outcomes [3] - Vynessa Alexander, Senior Vice President at Infor, is acknowledged for her extensive experience in technology and operations management, guiding young professionals in their career growth [4] Group 2: Additional Honorees - The list includes notable leaders from various industries such as Sherry Cassano (Pfizer), Jennifer Remling (Warner Bros. Discovery), and Marissa Tracey (Deutsche Bank), showcasing a diverse range of sectors represented [6] Group 3: Organization Overview - Women We Admire aims to recognize and inspire women leaders across various fields, circulating content to over 70,000 individuals and businesses [7]

On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he is sticking with NVIDIA Corporation (NASDAQ:NVDA) and not selling the stock.Nvidia surged on Tuesday, climbing past its 52-week high and becoming the first company to reach a $4.5 trillion market capitalization, as major tech firms continue to pour resources into artificial intelligence initiatives. The company's latest advancements include the open-source Newton Physics Engine, now integrated i ...

Core Insights - U.S. stocks experienced a decline, with the Dow Jones index dropping over 100 points on Wednesday [1] - Acuity Inc. reported better-than-expected fourth-quarter earnings, with an adjusted EPS of $5.20, surpassing the analyst consensus estimate of $4.84 [1] - Acuity's quarterly net sales grew by 17.1% year-over-year to $1.21 billion, slightly below the analyst consensus estimate of $1.23 billion [1] - Acuity's shares increased by 5.3% to $362.54 following the earnings report [1] Company Performance Highlights - Lithium Americas Corp. shares surged by 17.5% to $6.72 after an agreement with GM and the U.S. Department of Energy regarding its DOE loan [4] - Rezolve AI PLC's shares rose by 15.8% to $5.77 after raising its 2025 revenue target to $150 million ARR and setting a $500 million goal for 2026 [4] - The AES Corporation's shares increased by 14.2% to $15.02 amid reports of BlackRock's Global Infrastructure Partners nearing an acquisition [4] - Sunrun Inc. gained 12.7% to $19.49 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $11 to $21 [4] - Plug Power Inc. shares rose by 12.7% to $2.63 following the delivery of its first 10-megawatt GenEco™ electrolyzer array to Galp [4] - Hycroft Mining Holding Corporation's shares jumped by 10.7% to $6.87 [4] - United States Antimony Corporation shares gained 10.3% to $6.87 [4] - Upexi, Inc. increased by 9.7% to $6.33 [4] - Fluence Energy, Inc. rose by 8.3% to $11.70 [4] - Intellia Therapeutics, Inc. shares increased by 8.1% to $18.67 [4] - Standard Lithium Ltd. shares gained 8.1% to $3.6442 [4] - Zeta Global Holdings Corp. rose by 7.4% to $21.34, announcing plans to acquire Marigold's Enterprise business for up to $325 million [4] - Regeneron Pharmaceuticals, Inc. gained 5.6% to $593.71, with third quarter 2025 financial results set to be reported on Oct. 28 [4]

I have covered Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) twice before, and on both occasions, my predictions of share price performance on the basis of fundamental analysis were proved correct over the following months. MyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the ke ...

Core Insights - The article discusses the author's previous successful predictions regarding Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) share price performance based on fundamental analysis [1] - The author emphasizes the importance of patient investing and the accumulation of high-quality assets, alongside high-risk opportunities and transformative technologies [1] Company Analysis - Regeneron Pharmaceuticals has been a focus of the author's analysis, with a history of accurate predictions regarding its stock performance [1] - The author highlights the company's commitment to making a positive impact on the world through its business practices [1] Investment Philosophy - The investment approach combines steady accumulation of quality assets with high-risk, high-reward opportunities [1] - The author advocates for dividend reinvesting and the benefits of compounding over time [1]

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska, on May 3, 2025.Warren Buffett's Berkshire Hathaway is closing in on a deal to buy Occidental Petroleum's petrochemical unit OxyChem for roughly $10 billion, the Wall Street Journal reported Tuesday. The potential deal, which could finalize within days per the Journal, could be Berkshire's largest since 2022 when it bought insurer Alleghany for $11.6 billion. That deal was announced in March of that year and c ...

Spirit Airlines has negotiated funding of up to $475 million with existing bondholders to support normal business operations during its Chapter 11 restructuring, its parent company said on Tuesday. ...

Earlier on August 19, Erik Woodring of Morgan Stanley joined CNBC’s ‘The Exchange’ to discuss the most under-owned tech stocks and what’s behind the bifurcation in the sector. Woodring believes that mega-cap tech is under-owned in the market, as Morgan Stanley revealed that these stocks are the most under-owned by actively managed funds in over 16 years. The gap between the portfolio weightings of these stocks and their weightings in the S&P 500 index widened significantly in the second quarter. Despite thi ...